Placeholder Banner

Letter to Governor Deval Patrick

March 10, 2016

RE: Concerns with Senate Bill 2863

Dear Governor Patrick,

On behalf of the more than 1,200 members of the Biotechnology Industry Organization (BIO), I am writing to express concerns with SB 2863 "An Act to Control Cost Containment, Transparency and Efficiency in the Delivery of Quality Health Care." This legislation, currently pending your approval, contains provisions in Section 14 of the bill that could have serious unintended consequences on the Commonwealth's biotechnology industry.

As one of the world's leading medical centers and biotechnology industry hubs, we acknowledge the need for Massachusetts to be at the forefront of implementing policies to improve health care. In addition to the Life Science Initiative, the Commonwealth Care Program is an example of a progressive effort to address a concern affecting many states - creating access to affordable health insurance for all citizens. These programs have become national models and send a clear message that Massachusetts is serious about promoting life science innovation and improving access to quality health care.


 

Download Full Comments Below
20080807
Read the letter
Discover More
We write as a coalition of advocates for the startup ecosystem to voice our strong support for the IGNITE American Innovation Act, legislation to support startups through the economic crisis by allowing companies to monetize tax assets generated…
The Biotechnology Innovation Organization (BIO) is pleased to respond to the U.S. Department of Agriculture’s (USDA) Solicitation of Input from Stakeholders on Agricultural Innovations. BIO applauds USDA for taking a proactive approach and seeking…
July 31, 2020 Re: Docket No. FDA–2020-N-0837: Raare Disease Clinical Trial Network; Request for Information. Dear Sir/Madam: The Biotechnology Innovation Organization (BIO) thanks the Food and Drug Administration (FDA or Agency) for the…